Joint Optimal Power Control and Beamforming in Wireless Networks Using Antenna Arrays

The interference reduction capability of antenna arrays and the power control algorithms have been considered separately as means to increase the capacity in wireless communication networks. The MVDR (Minimum Variance Distortionless Responses) beamformer maximizes the Carrier to Interference Ratio (CIR) when it is employed in the receiver of a wireless link. In a system with omnidirectional antennas, power control algorithms are used to maximize CIR as well. In this paper we consider a system with beamforming capabilities in the receiver, and power control. an iterative algorithm is proposed to jointly update the transmission powers and the beamformer weights so that the coverage to the jointly optimal beamforming and transmission power vector. The algorithm is distributed and uses only local interference measurements. In an uplink transmission scenario it is shown how base assignment can be incorporated in addition to beamforming and power control such that a globally optimum solution is obtained. the network capacity increase and the saving in mobile power achieved by beamforming are evaluated through numerical study

Multi-user interference mitigation under limited feedback requirements for WCDMA systems with base station cooperation

One of the techniques that has been recently identified for dealing with multi-user interference (MUI) in future communications systems is base station (BS) cooperation or joint processing. However, perfect MUI cancellation with this technique demands severe synchronization requirements, perfect and global channel state information (CSI), and an increased backhaul and signaling overhead. In this paper, we consider a more realistic layout with the aim of mitigating the MUI, where only local CSI is available at the BSs. Due to synchronization inaccuracies and errors in the channel estimation, the system becomes partially asynchronous. In the downlink of wideband code division multiple access based systems, this asynchronism stands for the loss of the orthogonality of the spreading codes allocated to users and thus, for an increase in the MUI level of the system. In this contribution, we propose a framework for mitigating the MUI which builds in three main steps: definition of a cooperation area based on the channel characteristics, statistical modeling of the average MUI power experienced by each user and a specific spreading code allocation scheme for users served with joint processing. This code allocation assigns spreading codes to users in such a way that minimum average cross-correlation between active users can be achieved. Interestingly, these steps can be performed with a limited amount of extra feedback from the user's side

The Performance of SLNR Beamformers in Multi-User MIMO Systems

YesBeamforming in multi-user MIMO (MU-MIMO) systems is a vital part of modern wireless communication systems. Researchers looking for best operational performance normally optimize the problem and then solve for best weight solutions. The weight optimization problem contains variables in numerator and dominator: this leads to so-called variable coupling, making the problem hard to solve. Formulating the optimization in terms of the signal to leakage and noise ratio (SLNR) helps in decoupling the problem variables. In this paper we study the performance of the SLNR with variable numbers of users and handset antennas. The results show that there is an optimum and the capacity curve is a concave over these two parameters. The performances of two further variations of this method are also considered

European Position Paper on Rhinosinusitis and Nasal Polyps 2020

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise. The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included.Peer reviewe

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019

Background The causes for immune-mediated inflammatory diseases (IMIDs) are diverse and the incidence trends of IMIDs from specific causes are rarely studied. The study aims to investigate the pattern and trend of IMIDs from 1990 to 2019. Methods We collected detailed information on six major causes of IMIDs, including asthma, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, psoriasis, and atopic dermatitis, between 1990 and 2019, derived from the Global Burden of Disease study in 2019. The average annual percent change (AAPC) in number of incidents and age standardized incidence rate (ASR) on IMIDs, by sex, age, region, and causes, were calculated to quantify the temporal trends. Findings In 2019, rheumatoid arthritis, atopic dermatitis, asthma, multiple sclerosis, psoriasis, inflammatory bowel disease accounted 1.59%, 36.17%, 54.71%, 0.09%, 6.84%, 0.60% of overall new IMIDs cases, respectively. The ASR of IMIDs showed substantial regional and global variation with the highest in High SDI region, High-income North America, and United States of America. Throughout human lifespan, the age distribution of incident cases from six IMIDs was quite different. Globally, incident cases of IMIDs increased with an AAPC of 0.68 and the ASR decreased with an AAPC of −0.34 from 1990 to 2019. The incident cases increased across six IMIDs, the ASR of rheumatoid arthritis increased (0.21, 95% CI 0.18, 0.25), while the ASR of asthma (AAPC = −0.41), inflammatory bowel disease (AAPC = −0.72), multiple sclerosis (AAPC = −0.26), psoriasis (AAPC = −0.77), and atopic dermatitis (AAPC = −0.15) decreased. The ASR of overall and six individual IMID increased with SDI at regional and global level. Countries with higher ASR in 1990 experienced a more rapid decrease in ASR. Interpretation The incidence patterns of IMIDs varied considerably across the world. Innovative prevention and integrative management strategy are urgently needed to mitigate the increasing ASR of rheumatoid arthritis and upsurging new cases of other five IMIDs, respectively. Funding The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The project funded by Scientific Research Fund of Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital (2022QN38)

Wavelet-based Multiresolution Local Tomography

We develop an algorithm to reconstruct the wavelet coefficients of an image from the Radon transform data. The proposed method uses the properties of wavelets to localize the Radon transform and can be used to reconstruct a local region of the cross section of a body, using almost completely local data which significantly reduces the amount of exposure and computations in X-ray tomography. The property which distinguishes our algorithm from the previous algorithms is based on the observation that for some wavelet bases with sufficiently many vanishing moments, the rampfiltered version of the scaling function as well as the wavelet function has extremely rapid decay. We show that the variance of the elements of the null-space is negligible in the locally reconstructed image. Also we find an upper bound for the reconstruction error in terms of the amount of data used in the algorithm. To reconstruct a local region 16 pixels in radius in a 256 \Theta 256 image we require 22% of full expos..